HAX
HAX is a venture capital program focused on accelerating hardware startups through its comprehensive support and resources. Founded in 2012 and headquartered in Newark, New Jersey, HAX operates in two key locations, San Francisco and Shenzhen, providing founders with an environment conducive to rapid prototyping and iterative development. The program emphasizes the importance of launching both B2C and B2B hardware startups, guiding them through critical phases such as business development, fundraising, and market entry. HAX accepts teams that demonstrate strong potential for scaling their ventures and solving significant technological challenges. Through a structured curriculum, entrepreneurs refine their product-market fit and business strategies while benefiting from a robust network of mentors and industry connections. HAX maintains an ongoing relationship with participating startups to support their growth beyond the initial program, ensuring they have the necessary resources and partnerships to succeed in the competitive marketplace.
Top Stages
Past deals in Health Diagnostics
InnSight Technology
Seed Round in 2025
InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.
Seismi
Seed Round in 2024
Seismi is a veterinary healthcare company specializing in non-invasive, continuous monitoring solutions for pets. Their platform tracks vital signs such as heart rate, respiration, and blood pressure, providing pet owners with real-time, reliable health data, and reducing stress for both pets and owners. Additionally, Seismi offers cattle sensor technology and methane emission analytics, contributing to livestock health management and environmental sustainability.
Samphire Neuroscience
Seed Round in 2024
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.
ZiO Health
Convertible Note in 2024
ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.
FeetMe
Series B in 2024
FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.
Lief Therapeutics
Seed Round in 2024
Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.
Flowbio
Seed Round in 2024
Flowbio is a wellness and fitness services company that specializes in developing a real-time hydration biosensor platform aimed at athletes, including triathletes, cyclists, and runners. The company offers a wearable, non-invasive patch that monitors the body's hydration status by analyzing sweat at a molecular level. This technology captures critical biomarkers, such as electrolytes and total body fluid loss, providing users with personalized recommendations to enhance their athletic performance. By focusing on hydration management, Flowbio seeks to support athletes in optimizing their training and maintaining peak physical condition.
Strados Labs
Convertible Note in 2024
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.
Samphire Neuroscience
Pre Seed Round in 2024
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.
Lura Health
Seed Round in 2023
Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.
LightHearted AI
Seed Round in 2023
LightHearted AI is a company that specializes in developing an AI-driven remote cardiovascular diagnostics tool aimed at improving the detection of heart conditions. This medical device is designed to deliver rapid, precise, and cost-effective assessments, addressing the critical need to prevent heart-related deaths. By leveraging advanced technology, LightHearted AI enhances the capabilities of healthcare professionals, allowing for faster and more accurate diagnostic procedures compared to traditional methods. The company's innovation seeks to transform cardiac care, ultimately contributing to better treatment outcomes for patients.
Samphire Neuroscience
Convertible Note in 2023
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.
OpenShelf
Seed Round in 2023
OpenShelf is a company founded in 2023 that specializes in inventory automation for optometrists. It has developed a unique system that incorporates robotic technology to manage and distribute thousands of different contact lens boxes. This innovative "vending machine" style solution simplifies the inventory management process, allowing optometrists to efficiently handle, sort, and disperse contact lenses. Additionally, OpenShelf's software provides valuable data insights that help practitioners determine optimal reordering times for specific prescriptions and maintain appropriate stock levels.
DIA
Grant in 2023
Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.
Lief Therapeutics
Convertible Note in 2022
Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.
Untap Health
Seed Round in 2022
Untap Health develops a real-time wastewater monitoring system that detects and tracks infectious diseases. Its platform analyzes samples from commercial sites, schools, and healthcare facilities to identify potential outbreaks early, empowering organizations with actionable insights for effective disease prevention.
Bisu
Seed Round in 2022
Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.
Samphire Neuroscience
Seed Round in 2022
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.
Chronos DX
Seed Round in 2022
Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.
Kinexcs
Convertible Note in 2022
Kinexcs is an AI-driven health platform and wearables company dedicated to enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. The company addresses issues related to incomplete recovery and patient compliance by offering digital therapy solutions that are both affordable and convenient. Its flagship product, KIMIA, is the world's first continuous knee health monitor, which integrates with an AI-based digital therapist to provide real-time assessments and exercise guidance. Kinexcs collaborates with key opinion leaders and three major public hospitals in Singapore on various clinical projects and distributes its products through orthopedic surgeons and major implant manufacturers.
PONS
Pre Seed Round in 2022
PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.
Flowbio
Convertible Note in 2022
Flowbio is a wellness and fitness services company that specializes in developing a real-time hydration biosensor platform aimed at athletes, including triathletes, cyclists, and runners. The company offers a wearable, non-invasive patch that monitors the body's hydration status by analyzing sweat at a molecular level. This technology captures critical biomarkers, such as electrolytes and total body fluid loss, providing users with personalized recommendations to enhance their athletic performance. By focusing on hydration management, Flowbio seeks to support athletes in optimizing their training and maintaining peak physical condition.
Portable Diagnostic Systems
Seed Round in 2022
Portable Diagnostic Systems, established in August 2019, specializes in developing a microfluidics-based drug testing platform tailored for law enforcement agencies. Their innovative solution enables swift and accurate roadside saliva tests, reducing the need for guesswork during impaired driving traffic stops. The company's platform leverages salivary diagnostics, antibody engineering, and microfluidics to deliver precise results from small samples, thereby minimizing false positives and enhancing public safety.
Zennea Technologies
Convertible Note in 2022
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.
FoodMarble
Convertible Note in 2022
FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.
Harae Dx
Convertible Note in 2022
Harae Dx Corp. is a medical diagnostics company that has created a compact and portable multi-cancer detection system. This innovative platform enables automated cancer diagnostics by detecting cancer biomarkers directly, eliminating the need to send specimens to third-party laboratories. By reducing the potential for human processing errors and improving turnaround times for results, Harae Dx's technology allows healthcare professionals to identify and treat cancer at an early stage more effectively and affordably.
FeetMe
Convertible Note in 2022
FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.
Hydrostasis
Convertible Note in 2021
Hydrostasis develops a hydration monitor system for athletes to reach and maintain peak performance. The wearable sensors measure each athlete's optimal hydration range based on body composition and provide preventive notifications before dehydration symptoms affect performance. Based in San Diego, California, Hydrostasis collaborates with device manufacturers in both consumer and clinical applications to enable hydration monitoring capabilities. The company delivers personalized information with device-agnostic and clinical-grade accuracy and uses cloud-based data storage to deliver real-time, actionable hydration insights, enabling athletes to track their hydration ranges and sustain optimal performance.
Samphire Neuroscience
Seed Round in 2021
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.
Criam
Seed Round in 2021
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.
Neurode
Seed Round in 2021
Neurode develops a non-invasive wearable headset and companion software to treat and monitor ADHD-related symptoms by delivering electrical stimulation to balance brain activity, targeting cognitive functions such as working memory, attention, and impulse control. The drug-free approach supports medical professionals in improving cognitive performance, while the paired app tracks progress and shares data with clinicians for ongoing assessment and adjustment of treatment.
XXICO
Seed Round in 2021
XXICO is a platform consisting of devices and software that enable remote health monitoring.
Harae Dx
Seed Round in 2021
Harae Dx Corp. is a medical diagnostics company that has created a compact and portable multi-cancer detection system. This innovative platform enables automated cancer diagnostics by detecting cancer biomarkers directly, eliminating the need to send specimens to third-party laboratories. By reducing the potential for human processing errors and improving turnaround times for results, Harae Dx's technology allows healthcare professionals to identify and treat cancer at an early stage more effectively and affordably.
Neurocess
Seed Round in 2021
Neurocess develops wearable technology designed to enhance athletic performance and reduce injury risks. Their product attaches sensors to monitor muscle signals during training sessions, providing valuable insights like muscle balance, fatigue levels, and dehydration status to coaches and athletes.
FoodMarble
Seed Round in 2020
FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.
RxAll
Convertible Note in 2020
RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.
Strados Labs
Convertible Note in 2020
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.
Sepsitron
Pre Seed Round in 2020
Sepsitron is a medical diagnostic technology company focused on the early detection of blood infections. Its innovative approach utilizes a combination of unique biomarkers, microfluidics, and advanced electronics to enable rapid identification of multiple pathogens—including viral, bacterial, parasitic, and fungal—using a single test. The device is designed for point-of-care applications, offering a significant advantage by delivering results 50 times faster and at one-tenth the cost of conventional methods. Importantly, Sepsitron's tests do not require any sample pre-processing and can analyze whole blood samples, allowing healthcare professionals to diagnose and initiate treatment for infections more efficiently.
Lura Health
Convertible Note in 2020
Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.
RxAll
Seed Round in 2020
RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.
Zennea Technologies
Seed Round in 2020
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.
Intelligent Implants
Series A in 2019
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.
Sepsitron
Pre Seed Round in 2019
Sepsitron is a medical diagnostic technology company focused on the early detection of blood infections. Its innovative approach utilizes a combination of unique biomarkers, microfluidics, and advanced electronics to enable rapid identification of multiple pathogens—including viral, bacterial, parasitic, and fungal—using a single test. The device is designed for point-of-care applications, offering a significant advantage by delivering results 50 times faster and at one-tenth the cost of conventional methods. Importantly, Sepsitron's tests do not require any sample pre-processing and can analyze whole blood samples, allowing healthcare professionals to diagnose and initiate treatment for infections more efficiently.
FoodMarble
Convertible Note in 2019
FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.
RxAll
Pre Seed Round in 2019
RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.
UCHU Biosensors
Seed Round in 2019
UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.
Seein Health
Venture Round in 2019
Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.
Intelligent Implants
Convertible Note in 2019
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.
Zennea Technologies
Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.
Kinexcs
Seed Round in 2019
Kinexcs is an AI-driven health platform and wearables company dedicated to enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. The company addresses issues related to incomplete recovery and patient compliance by offering digital therapy solutions that are both affordable and convenient. Its flagship product, KIMIA, is the world's first continuous knee health monitor, which integrates with an AI-based digital therapist to provide real-time assessments and exercise guidance. Kinexcs collaborates with key opinion leaders and three major public hospitals in Singapore on various clinical projects and distributes its products through orthopedic surgeons and major implant manufacturers.
ZiO Health
Seed Round in 2019
ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.
Bravrr
Pre Seed Round in 2019
Bravrr, LLC is a company based in Canon City, Colorado, founded in 2019, that specializes in the development of wearable diagnostic and therapeutic tools. Its flagship product, BruxRelief, is a smart biofeedback wearable designed to address bruxism disorder, which affects about one in three people yet remains largely undiagnosed. BruxRelief is an innovative headband equipped with advanced sensors and artificial intelligence to monitor and analyze users' clenching and grinding behaviors related to bruxism. By connecting to a smartphone app, it provides insights into nighttime bruxism activities and sleep patterns, enabling users to identify stress triggers and adopt measures to mitigate these harmful behaviors. Bravrr aims to revolutionize the bruxism market, which is valued at over $9 billion, by offering a user-friendly and effective alternative to traditional, complex diagnostic devices.
Strados Labs
Seed Round in 2019
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.
Vision Infinitas
Seed Round in 2019
Vision Infinitas is a company focused on leveraging wearable technology to enhance personal nourishment and energy optimization. Its primary product is a wearable sensor that autonomously monitors the energy levels within the body while simultaneously tracking food and beverage intake. Operating in stealth mode, Vision Infinitas is developing innovative solutions aimed at improving individual well-being through advanced sensory information. The company's commitment is to empower users with detailed insights into their nutritional habits and energy management.
Vitrix Health
Pre Seed Round in 2019
Vitrix Health, Inc. is a company that designs, develops, and manufactures innovative screening tools for the healthcare industry, specifically focusing on early-stage detection of oral diseases and cancers. Founded in 2018 and headquartered in Champaign, Illinois, Vitrix Health utilizes a combination of optics and machine learning on a mobile platform to enhance the effectiveness of oral health screenings conducted by primary care providers. This technology addresses the significant number of Americans who do not visit dentists regularly, thereby improving overall health outcomes and reducing costs. The company's oral cancer screening device is currently undergoing pilot testing in various prestigious institutions, including Mt. Sinai Hospital and the University of Chicago Medical School, in addition to international clinical trials in Bolivia and India. By empowering primary care providers to detect oral diseases, Vitrix Health aims to bridge disparities in oral health and ensure timely referrals for dental care.
Bisu
Convertible Note in 2019
Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.
Zennea Technologies
Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.
Lura Health
Seed Round in 2019
Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.
Biospin
Seed Round in 2018
Biospin is an introducing a revolutionary microbial detection system that provides gold standard detection of pathogens for F&B, water, consumer goods and pharmaceutical products in real time.
Kinexcs
Seed Round in 2018
Kinexcs is an AI-driven health platform and wearables company dedicated to enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. The company addresses issues related to incomplete recovery and patient compliance by offering digital therapy solutions that are both affordable and convenient. Its flagship product, KIMIA, is the world's first continuous knee health monitor, which integrates with an AI-based digital therapist to provide real-time assessments and exercise guidance. Kinexcs collaborates with key opinion leaders and three major public hospitals in Singapore on various clinical projects and distributes its products through orthopedic surgeons and major implant manufacturers.
Intelligent Implants
Seed Round in 2018
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.
Seein Health
Seed Round in 2018
Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.
ZiO Health
Seed Round in 2018
ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.
Hisens
Seed Round in 2018
Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.
FoodMarble
Seed Round in 2018
FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.
HabitAware
Seed Round in 2018
HabitAware, Inc. is a Minneapolis-based company that develops wearable devices aimed at helping individuals manage compulsive behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. The company's flagship product, Liv, is a smart awareness bracelet that utilizes motion sensors to detect these subconscious actions. It connects to a mobile application that provides users with training to recognize and track their behaviors, identify triggers, and implement healthier coping strategies. Founded in 2014, HabitAware combines technology with behavioral science to empower users, particularly those affected by trichotillomania, to gain awareness and control over their habits. The products are available for purchase online.
Zennea Technologies
Pre Seed Round in 2018
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.
Criam
Convertible Note in 2018
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.
Pillsy
Seed Round in 2017
Pillsy is an enterprise-grade platform for remote patient support and rapid development of connected medication experiences. It is a new smart pill bottle and app that uses behavioral science to support healthy habits around vitamins and medications. It also securely share the pill-taking information with loved ones and to help monitor people.
Pillsy was founded in 2015 and is headquartered in Seattle, Washington.
AptaCam
Pre Seed Round in 2017
AptaCam is a biotechnology company based in Shenzhen, China, founded in 2014. The company specializes in developing biosensors for the detection of human papillomavirus (HPV) and other infectious diseases. AptaCam is also focused on creating a software solution that enhances the functionality of its portable diagnostic devices, allowing for effective data analysis and collection when connected to a computer. In addition to its biosensor technology, AptaCam aims to be a leading producer of high-quality aptamers, which are short, single-stranded nucleic acid molecules with high affinity and specificity for targeted applications. The company's innovative approach is designed to advance molecular recognition and support a wide range of disciplines, including clinical diagnostics, drug discovery, environmental monitoring, and food safety.
Kinexcs
Pre Seed Round in 2017
Kinexcs is an AI-driven health platform and wearables company dedicated to enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. The company addresses issues related to incomplete recovery and patient compliance by offering digital therapy solutions that are both affordable and convenient. Its flagship product, KIMIA, is the world's first continuous knee health monitor, which integrates with an AI-based digital therapist to provide real-time assessments and exercise guidance. Kinexcs collaborates with key opinion leaders and three major public hospitals in Singapore on various clinical projects and distributes its products through orthopedic surgeons and major implant manufacturers.
Bisu
Pre Seed Round in 2017
Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.
Revvo
Convertible Note in 2017
Revvo specializes in innovative fitness equipment. Its flagship product is a stationary bike that accurately measures key health indicators such as VO2Max, recovery time, and endurance through a guided 15-minute test, eliminating the need for lab visits or face masks.
ZiO Health
Convertible Note in 2017
ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.
Digi.Bio
Seed Round in 2017
Digi.Bio is a Netherlands-based company specializing in software development for the healthcare sector, focusing on automating liquid handling processes through advanced microfluidic technology. The company offers a lab-on-a-chip and computational platform designed to enhance the efficiency and accuracy of cell therapy development, allowing for rapid analysis of therapeutic outcomes at the single-cell level. By employing artificial intelligence and electrowetting techniques, Digi.Bio's platform enables medical and pharmaceutical laboratories to automate repetitive workflows, significantly reducing material waste and accelerating the bioengineering process. The innovative solutions provided by Digi.Bio aim to streamline multistep liquid handling applications, replacing traditional pipetting methods and facilitating the advancement of life-saving cell therapies.
Mojo
Pre Seed Round in 2017
For everyone who wants to expand their family-building potential, Mojo offers an online fertility care platform helping humans to test, understand and improve their fertility. Unlike current fertility care systems, which are only accessible by the privileged few at high costs and inferior effectiveness, the Mojo platform is accessible to everyone and powered by AI to ensure an unmatched level of effectiveness, scientific standard, and convenience at remarkable pricing.
ZiO Health
Seed Round in 2017
ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.
Intelligent Implants
Seed Round in 2017
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.
Hisens
Convertible Note in 2016
Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.
Vitali Wear
Convertible Note in 2016
Vitali Wear is a Vancouver-based company founded in 2016 that specializes in the development of innovative wellness apparel, specifically a smart bra designed for everyday use. This product incorporates fabric sensors that monitor key indicators such as breathing, posture, and heart rate variability, allowing users to gain insights into their bodily patterns and overall well-being. The data collected is transmitted to a mobile application, which tracks personal goals and progress while also providing access to breathing and meditation exercises. Vitali Wear aims to promote mindfulness and resilience through its technology, encouraging users to foster a deeper connection with themselves and enhance their everyday health.
Criam
Convertible Note in 2016
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.
Vitali Wear
Seed Round in 2016
Vitali Wear is a Vancouver-based company founded in 2016 that specializes in the development of innovative wellness apparel, specifically a smart bra designed for everyday use. This product incorporates fabric sensors that monitor key indicators such as breathing, posture, and heart rate variability, allowing users to gain insights into their bodily patterns and overall well-being. The data collected is transmitted to a mobile application, which tracks personal goals and progress while also providing access to breathing and meditation exercises. Vitali Wear aims to promote mindfulness and resilience through its technology, encouraging users to foster a deeper connection with themselves and enhance their everyday health.
Criam
Seed Round in 2016
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.
Intelligent Implants
Seed Round in 2016
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.
Hisens
Seed Round in 2016
Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.
my.Flow
Convertible Note in 2016
My.Flow, Inc. is a San Francisco-based company founded in 2015 that specializes in the development of innovative menstrual devices. The company has created a small, discreet monitor designed to track menstrual flow by measuring the amount of blood absorbed by tampons. This device alleviates common concerns such as period anxiety, leakage, and the risk of infection. It attaches to clothing and communicates with a mobile application to alert users when a tampon is full and needs to be changed. My.Flow aims to empower women by providing insights into their menstrual health, challenging outdated menstrual solutions, and fostering open discussions about menstruation.
HabitAware
Convertible Note in 2016
HabitAware, Inc. is a Minneapolis-based company that develops wearable devices aimed at helping individuals manage compulsive behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. The company's flagship product, Liv, is a smart awareness bracelet that utilizes motion sensors to detect these subconscious actions. It connects to a mobile application that provides users with training to recognize and track their behaviors, identify triggers, and implement healthier coping strategies. Founded in 2014, HabitAware combines technology with behavioral science to empower users, particularly those affected by trichotillomania, to gain awareness and control over their habits. The products are available for purchase online.
FoodMarble
Convertible Note in 2016
FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.
my.Flow
Pre Seed Round in 2016
My.Flow, Inc. is a San Francisco-based company founded in 2015 that specializes in the development of innovative menstrual devices. The company has created a small, discreet monitor designed to track menstrual flow by measuring the amount of blood absorbed by tampons. This device alleviates common concerns such as period anxiety, leakage, and the risk of infection. It attaches to clothing and communicates with a mobile application to alert users when a tampon is full and needs to be changed. My.Flow aims to empower women by providing insights into their menstrual health, challenging outdated menstrual solutions, and fostering open discussions about menstruation.
Berkeley Ultrasound
Convertible Note in 2015
Berkeley Ultrasound, established in 2014, focuses on advancing the use of ultrasound technology as a brain stimulation tool. The company has developed a platform that employs transcranial ultrasound stimulation to investigate and treat brain diseases, particularly targeting conditions such as Alzheimer's and dementia. Their ultrasound device facilitates various scanning modes, pulsing techniques, and adjustable depth stimulation, allowing neuroscience researchers to explore the intricate networks of the human brain effectively. Berkeley Ultrasound aims to provide frictionless access to its innovative technology for investigative and non-clinical applications, contributing to advancements in neuroscience and brain health.
Berkeley Ultrasound
Seed Round in 2015
Berkeley Ultrasound, established in 2014, focuses on advancing the use of ultrasound technology as a brain stimulation tool. The company has developed a platform that employs transcranial ultrasound stimulation to investigate and treat brain diseases, particularly targeting conditions such as Alzheimer's and dementia. Their ultrasound device facilitates various scanning modes, pulsing techniques, and adjustable depth stimulation, allowing neuroscience researchers to explore the intricate networks of the human brain effectively. Berkeley Ultrasound aims to provide frictionless access to its innovative technology for investigative and non-clinical applications, contributing to advancements in neuroscience and brain health.
BrainBot
Seed Round in 2015
BrainBot is a company focused on developing innovative brain sensing applications aimed at improving overall health and well-being. Founded with the inspiration of measuring the brainwaves of meditating monks in the Himalayan mountains, the company leverages neuroscience technology to help users enhance resilience against anxiety, depression, chronic pain, addiction, and eating disorders. Through their applications, BrainBot enables individuals to decrease stress and improve cardiovascular health by promoting effective meditation practices. The company's commitment to integrating technology with mental wellness reflects its vision to facilitate better health outcomes for users.
FeetMe
Seed Round in 2015
FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.
Lir
Seed Round in 2015
Lir is a company focused on addressing the significant and underserved market of bladder management, valued at approximately 20 billion dollars. It is developing an innovative pre-emptive bladder fullness sensor, which represents a breakthrough in non-invasive bladder monitoring. This sensor, designed to be worn around the waist, utilizes Bluetooth technology to detect tissue changes associated with bladder fullness and sends alerts directly to a paired smart device. Unlike traditional methods that require bulky and non-portable ultrasound systems typically found in hospitals, Lir's product is discreet, affordable, and user-friendly, allowing individuals with bladder management issues to enhance their quality of life. This development positions Lir as a leader in the integration of technology and personal health management.
BBB Technologies
Seed Round in 2015
BBB Technologies Inc. is a mobile healthcare technology company focused on blood-based diagnostics and data-driven insights to support early disease detection, treatment decisions, and remote monitoring for patients and clinicians. Founded in 2014 and based in Mountain View, California, with offices in Seoul and Shenzhen, it develops blood testing technologies and mobile-enabled tools that deliver rapid results and actionable insights. The company leverages artificial intelligence to analyze blood biomarkers and enable at-home testing and remote patient monitoring, aiming to broaden access to diagnostics across multiple conditions.
Ninu
Seed Round in 2015
Ninu is a free app that provides information about the entire nine months of pregnancy and tips on health, nutrition, and baby’s development stages. It offers personalized pregnancy information for mothers-to-be, their partners, and doctors.
Wearable sensors collect data such as baby movements, pains, baby kicks, stress level, and sleep patterns to provide insights on issues like preterm birth risks, pains, and lifestyle. Visualized data enables pregnant mothers to objectively discuss symptoms with doctors and the Ninu community.
Ninu is operated from Munich, Germany.
Lief Therapeutics
Seed Round in 2015
Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.
Darma
Pre Seed Round in 2014
Darma Inc. is a health technology company based in the United States that specializes in non-invasive health monitoring solutions. The company has developed an innovative non-wearable health tracking device known as the DARMA cushion, which allows users to monitor their vital signs through an integrated application while seated. This cushion not only provides real-time data on stress levels, sitting time, and posture but also offers reminders and alerts to encourage users to stand up and improve their posture. Additionally, Darma's technology includes advanced fiber optic biosensors designed for placement under mattresses, facilitating continuous monitoring of vital signs and cardiac performance without direct contact. By combining bio-sensing technology with cloud-based algorithms and healthcare management services, Darma aims to assist patients, caregivers, and healthcare providers in proactive health management, reducing hospital readmissions, and enhancing overall quality of life.
Vigo
Pre Seed Round in 2013
Vigo Technologies Inc. specializes in the development and marketing of wearable devices designed to monitor eye and head movements to assess alertness levels. The technology tracks various parameters, including blink rates, blink durations, and postural changes, such as head nods and slouched positions. When the device identifies signs of drowsiness, it employs a combination of stimuli—such as vibrations, music, audio cues, flashing lights, or phone calls—to re-engage the user. By quantifying alertness in real-time, Vigo enables users to recognize patterns in their alertness levels, facilitating better energy management and overall awareness. Founded in 2014, the company is headquartered in San Francisco, California.
Notch
Pre Seed Round in 2013
Personal trainer powered by wearable technology and fitness experts & celebrities that guides you through workouts with live audio feedback. Train with Notch to get real-time guidance and motivation on your form, reps, and amount of weights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.